Clinical Trial

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Study acronym: NEURO_CAR-T
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, multicenter, prospective cohort study including patients treated with CAR-T in Italian centers. Patients eligible for enrollment in the study will be consecutively included in Italian FIL centers. A longitudinal survey will be carried out by collecting patients' data before starting CAR-T (T0) and after 6 (T1), 12 (T2) and 24 (T3) months after CAR-T infusion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-05.
Trial Details
NCT Number NCT07463781
Lead Sponsor Fondazione Italiana Linfomi - ETS
Collaborators: Fondazione Lorenzo Farinelli Onlus
Conditions Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)
Enrollment 100 participants
Start Date 2026-05
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-13